Skip to main content

MIT Corporate Relations

MIT Corporate Relations
MIT Logo
  • Events
  • STEX25
  • Startups
  • opportunities
  • MIT ILP
  • Sign-In
  • Register Your Startup
  • Search
STEX Home
  • Events
    • Corporates
    • Event Videos
    • Startups
  • STEX25
    • Featured
    • Videos
  • Startups
    • Search
    • News
  • opportunities
  • MIT ILP
User Menu and Search
  • Sign-In
  • Register Your Startup
STEX Home
Toggle menu
  • Sign-in
  • Register your startup
  • Events
    • Corporates
    • Event Videos
    • Startups
  • STEX25
    • Featured
    • Videos
  • Startups
    • Search
    • News
  • opportunities
  • MIT ILP

Search Results


Filter Results
Staff

Filter Results

Narrow your search results
  • News (12)
  • Videos (46)
  • Events (5)
  • Startup Opportunities (35)
  • Startups
  • Founders
Please sign-in to see the full search results
106 search results found
  • Kytopen Corporation

    Cambridge, MA
    Biotechnology
    Kytopen is developing platforms to accelerate the discovery and manufacturing of next-generation cell & gene therapies. The Flowfect technology offers a scalable, non-viral solution to deliver genetic payloads to cells in order to augment their functionality. The technology also enables continuous... More
    Keywords:
    Flowfect(R), Non-Viral, Gene Editing, CRISPR delivery, Continuous Processing, cell therapy, Genome Engineering, CAR T-cells, Engineered TCR T-cells
    Kytopen
  • AgTech 2018_Merry Smith

    AgTech Workshop 2018 - Startup Lighting Talks

    September 26, 2018 | Startup Exchange Video | Duration: 32:7

     

    Scalable production of RNA for agriculture
      Andrey Zarur, Cofounder & CEO, GreenLight Biosciences
    Potassium fertilizer innovation
      Philip Wender, Managing Director, Advanced Potash Technologies 
    Chemiresistive gas sensing for food safety
      Merry Smith, Senior Scientist, C2Sense
    Novel dehumidifying material for indoor farms
      Sorin Grama, Cofounder, Transaera 
    Probiotics for plants 
      Michael Miille, CEO, Joyn Bio [Joyn is a JV between Ginkgo Bioworks and Leaps by Bayer]

  • GVD-Price

    GVD Corporation

    December 1, 2014 | Startup Exchange Video | Duration: 14:23

    Hilton Pryce Lewis, Co-founder, President and CEO, GVD Corporation

  • Natalya Baily, CEO & Cofounder, Accion

    Accion Systems

    November 22, 2017 | Startup Exchange Video | Duration: 21:39

    Natalya Baily, CEO & Cofounder, Accion

  • Aerva-Manandhar

    Aerva

    May 18, 2015 | Startup Exchange Video | Duration: 15:14

    Sanjay Manandhar, Aerva Founder & CEO

  • Andrew A. Radin, Cofounder & CTO; & Andrew M. Radin, Cofounder & Chief Marketing Officer, twoXAR

    Aria Pharmaceuticals

    January 9, 2019 | Startup Exchange Video | Duration: 15:5

    Andrew A. Radin & Andrew M. Radin

  • BioBuilder

    April 25, 2016 | Startup Exchange Video | Duration: 15:21

    Natalie Kuldell, President, Founder, & Executive Director, BioBuilder Educational Foundation

  • Rana el Kaliouby, CEO & Cofounder, Affectiva

    Affectiva

    July 6, 2017 | Startup Exchange Video | Duration: 21:37

    Rana el Kaliouby, CEO & Cofounder, Affectiva

  • Rei Goffer, Cofounder & Chief Strategy Officer, ClimaCell

    ClimaCell

    January 15, 2019 | Startup Exchange Video | Duration: 19:46

    Rei Goffer, Cofounder & Chief Strategy Officer, ClimaCell

  • Aditya Khosla, Cofounder & CTO, PathAI

    PathAI

    November 15, 2018 | Startup Exchange Video | Duration: 21:45

    PathAI is evolving pathology using machine learning and deep learning techniques to drive faster more accurate diagnosis of disease.

Pagination

  • of 9
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • Next page
  • Events
    • Corporates
    • Event Videos
    • Startups
  • STEX25
    • Featured
    • Videos
  • Startups
    • Search
    • News
  • opportunities
  • MIT ILP
  • Twitter
  • YouTube
  • LinkedIn
Home

1 Main Street
12th Floor, E90-1201
Cambridge, MA 02142


Accessibility

Privacy Policy

617-253-2691
startupexchange@mit.edu

Office of Corporate Relations